SERUM SORUBLE CD27 LEVEL DETERMINES CLINICAL OUTCOME IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN RITUXIMAB ERA

被引：0
|
作者：
Coto, N.
Tsurumi, H. [1 ]
Kanemura, N. [1 ]
Kasahara, S. [1 ]
Hara, T. [1 ]
Kito, Y. [2 ]
Takami, T. [2 ]
Moriwaki, H. [1 ]
Nakamura, H. [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0671
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era
    Goto, Naoe
    Tsurumi, Hisashi
    Kasahara, Senji
    Hara, Takeshi
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Ninomiya, Soranobu
    Ogawa, Kengo
    Yamada, Toshiki
    Sawada, Michio
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    BLOOD, 2009, 114 (22) : 764 - 764
  • [2] Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone
    Goto, Naoe
    Tsurumi, Hisashi
    Takemura, Masao
    Kanemura, Nobuhiro
    Kasahara, Senji
    Hara, Takeshi
    Yasuda, Ichiro
    Shimizu, Masahito
    Yamada, Toshiki
    Sawada, Michio
    Takahashi, Takeshi
    Yamada, Tetsuya
    Seishima, Mitsuru
    Moriwaki, Hisataka
    Takami, Tsuyoshi
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1494 - 1500
  • [3] CLINICAL SIGNIFICANCE OF BIOMARKERS OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Niitsu, N.
    Hayama, M.
    Hagiwara, Y.
    Tanae, K.
    Kohri, M.
    Takahashi, N.
    ANNALS OF ONCOLOGY, 2011, 22 : 154 - 154
  • [4] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [5] Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcome
    Rozman, Samo
    Grabnar, Iztok
    Novakovic, Srdjan
    Mrhar, Ales
    Novakovic, Barbara Jezersek
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (08) : 1782 - 1790
  • [6] Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era
    Mounier, Nicolas
    Gisselbrecht, Christian
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 209 - 213
  • [7] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Takeshi Hara
    Hisashi Tsurumi
    Naoe Goto
    Nobuhiro Kanemura
    Takeshi Yoshikawa
    Senji Kasahara
    Toshiki Yamada
    Michio Sawada
    Hideko Goto
    Kenji Fukuno
    Jun-ichi Kitagawa
    Ichiro Yasuda
    Naoki Katsumura
    Masao Takemura
    Takeshi Takahashi
    Tsuyoshi Takami
    Hisataka Moriwaki
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1421 - 1428
  • [8] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Hara, Takeshi
    Tsurumi, Hisashi
    Goto, Naoe
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Goto, Hideko
    Fukuno, Kenji
    Kitagawa, Jun-ichi
    Yasuda, Ichiro
    Katsumura, Naoki
    Takemura, Masao
    Takahashi, Takeshi
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1421 - 1428
  • [9] Clinical Characteristics and Outcome of Transformed Diffuse Large B-Cell Lymphoma in the Rituximab Era: A SEER Database Analysis
    Wang, Yucai
    Wang, Yanru
    Wang, Michael
    Thanarajasingam, Gita
    Thompson, Carrie
    Nowakowski, Grzegorz
    Habermann, Thomas
    Ansell, Stephen
    Witzig, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S362 - S362
  • [10] Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era
    Lehners, N.
    Herth, I
    Egerer, G.
    Ho, A. D.
    Witzens-Harig, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 261
12345